Status:
UNKNOWN
Comparison of Meperidine and Sufentanil Added to 0.5% Hyperbaric Bupivacaine for Spinal Anesthesia in Cesarean Section
Lead Sponsor:
Makassed General Hospital
Conditions:
Analgesia
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Subarachnoid block is a widely used anesthetic technique for cesarean section. To improve the quality of analgesia and prolong its duration, the addition of intrathecal opioids to local anesthetics ha...
Detailed Description
A questionnaire will be used to collect data. Patients' demographic and operative characteristics will be recorded. These include block level, heart rate, mean arterial pressure, nausea, vomiting, shi...
Eligibility Criteria
Inclusion
- pregnant women with American Society of Anesthesiologist (ASA) 2-3
- scheduled for elective cesarean section.
Exclusion
- refuse to participate in the study,
- requiring emergency obstetric care,
- ASA IV or V,
- having systemic diseases,
- a known fetal anomaly,
- placenta previa,
- abruption placenta
- with a history of hypersensitivity or allergy to any of the study drugs,
- operation time longer than 1.5 hour,
- blood loss more than 1500 millilitres,
- those with any contraindication to the technique proposed,
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04446715
Start Date
October 1 2020
End Date
August 1 2021
Last Update
July 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Makassed General Hospital
Beirut, Lebanon